Educational Materials

Click the items below for more information and materials. 

Chronic Care Improvement Program (CCIP) and Quality Improvement Program (QIP) Information: Heart Failure Education

A CMS-mandated program, the Chronic Care Improvement Program (CCIP) is designed to reduce hospitalizations for our Medicare members diagnosed with congestive heart failure. The program is closely aligned with the Million Hearts Campaign, which has a goal of significantly reducing the number of strokes and heart attacks over five years.

Similarly, the Quality Improvement Program (QIP) is designed to reduce all-cause re-admissions for Medicare members who have a heart failure diagnosis by focusing on medication adherence and care coordination. The QIP is aligned with the national Partnership for Patients campaign.

Fidelis Care is proud to provide the following links to additional information on best practices and clinical guidelines:

National Guidelines Clearinghouse - AHRQ - US Dept. of Health and Human Services

Chronic Disease Management Programs
Fidelis Care is committed to supporting members with chronic diseases through programs that help them better manage their health through a combination of education and care planning.
Once diagnosed, members can access our disease management programs in two ways: written information that is mailed to their home, or one-on-one phone outreach from a Nurse Case Manager. 
We provide important educational information in our newsletters and on our website, fideliscare.org, as well as through customized letters, brochures, and other materials that are sent to members.
Through our Disease Management Nurse Case Managers, Fidelis Care connects with members individually on a regular basis, helping to:
  • Prevent or manage disease complications
  • Coordinate appointments with primary care providers and specialists
  • Manage medications
  • Arrange for in-home equipment or services for more independent living
  • Connect with community resources and services
  • Make positive lifestyle changes
  • Provide moral support

Fidelis Care’s Disease Management Nurse Case Managers also serve as a direct link between our members and their health care providers. We regularly contact provider offices by phone, fax, or letter to alert them of changes in a member’s health status or care, as well as to collect relevant medical data that may help us provide better service and assistance.
Fidelis Care regularly evaluates the effectiveness of our disease management programs, and we value your feedback and participation in this process. 
If you have questions or feedback about a specific Fidelis Care disease management program, or would like to refer a patient to one of our programs, please call 1-800-247-1441, or email triage@fideliscare.org.
 
Fidelis Care is proud to be your partner in providing the highest quality care and service to our members and your patients. 
Clinical Practice Guidelines
Clinical Practice Guidelines have been developed to aid the practitioner in clinical decision-making for specific circumstances. Guidelines describe appropriate clinical care procedures and processes based on the best available scientific and peer-reviewed evidence and wide-ranging consensus—the main source for evidence-based care. The goal of evidence–based care is to support quality of care and consistency in healthcare delivery.

National Guideline Clearinghouse (AHRQ) found at guidelines.gov, is a website containing recognized clinical practice guidelines developed by professional specialty groups or federally funded research. You can search subjects linked to particular terminology used in classifications for diseases and treatments.

The United States Preventive Service Task Force (USPSTF) is a website containing recommendations for preventive health care services in primary care developed through scientific evidence reviews of clinical research. These recommendations can be found via ahrq.gov or uspreventiveservicestaskforce.org.

Additionally, many professional organizations such as the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, and the American College of Physicians develop clinical practice guidelines specific to their area of medical specialty.
HealthierLife and Behavioral Health Resources

HealthierLife Performance Improvement Project (PDF)

Self-Help and Resource Guide (PDF)

Evidence Based Practices Resource Center

Prevent Suicide NY

Suicide Prevention Lifeline

National Institute for Mental Health Resources 


Behavioral Health Uniform Network Provider Training Program

Fidelis Care participates in a collaboration with New York State Health Plan Association, Center for Practice Innovations, and the Center on Addiction to provide a uniform clinical online training in core competencies to licensed OMH clinics and PROs providers, as well as licensed OASAS clinic programs statewide. Programs are strongly encouraged to take advantage of this training resource.

Learn how to get started

Project TEACH

To support the critical role that pediatricians and primary care physicians play in the early identification and access to treatment for emotional disturbances in children, the New York State Office of Mental Health (OMH) is funding a collaborative effort of State and County governments with medical providers designed to link pediatricians and primary care physicians with child mental health experts across New York State.

Project TEACH (Training and Education for the Advancement of Children’s Health) will provide specialized training, consultation and linkage with mental health treatment for primary care physicians statewide.  It is a collaboration of OMH with the Department of Health (DOH), Conference of Local Mental Hygiene Directors, American Academy of Pediatrics (AAP) and the New York State Academy of Family Physicians (AAFP).

Review evidence based questionnaires and rating scales for the screening, diagnosis, and monitoring of  a range of behavioral health needs for pediatricians. 

For more information, visit the Project TEACH website, the New York State Office of Mental Health website, or contact Dr. David Kaye, Project Director at 716-887–5775.

Weight Assessement and Counseling for Children and Adolescents (WCC)
Pediatric Toolkit for Providers

Medicaid, Child Health Plus, and Healthier Life:
Formulary Changes and Effective Dates

Fidelis Care has made changes to our Medicaid Managed Care, Child Health Plus (CHP), and HealthierLife (HARP) Formulary effective April 1, 2022. Some of the changes relate to quantity limitations, authorization requirements, as well as drugs being removed and added to the formulary. Please see the full list here.


 

Drug Action Effective Date
Buprenorphine/Naloxone (Zubsolv)** • Add with QL 03/22/2022
Buprenorphine/Naloxone film (Suboxone)**  • Add generic with QL (Brand already Formulary) 03/22/2022
Naloxone (Kloxxado)** • Add 03/22/2022
Memantine ER • Add with ST of memantine IR 04/01/2022
Procrit/Epogen • Add with PA 04/01/2022
Ruconest • Add with PA 04/01/2022
Cinryze • Add with PA 04/01/2022
Invega Hafyera • Add with PA 04/01/2022
Teriflunomide (Aubagio) • Add QL 04/01/2022
Ambrisentan (Letairis) • Add QL 04/01/2022
Fingolimod (Gilenya) • Add QL 04/01/2022
Sponimod (Mayzent) • Add QL 04/01/2022
Sponimod (Mayzent) Titration Pack • Add with QL 04/01/2022
Actemra* • Add with PA/QL 04/01/2022
Stelara* • Add with QL 04/01/2022
Buprenorphine/Naloxone (Zubsolv)** • Add with QL 04/01/2022

* Change for CHP Only; Change will not affect NYM/HARP
** Change for NYM/HARP Only; Change will not affect CHP

 

2022 Medicare Monthly Prescription Drug Premiums with Extra Help

If you get extra help from Medicare to help pay for your Medicare prescription drug plan costs, your monthly plan premium will be lower than what it would be if you did not get extra help from Medicare.  The amount of extra help you get will determine your total monthly plan premium as a member of our Plan.


Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Level of Extra Help Wellcare Fidelis Dual Access
(Plan 001)

Wellcare Fidelis Assist
(Plan 002)

Non LIS $20 $17.10
Non LIS $20 $17.10

 

The New York State Executive Budget for State Fiscal Year 2020-2021, in accordance to § 367-a (7) (e) of Social Services Law, will enact a statewide formulary for Opioid Antagonists and Opioid Dependence Agents for Medicaid Managed Care (MC) Plans and Medicaid Fee for Service (FFS) Program. Under this statewide formulary, Medicaid MC and FFS members will follow a single formulary, where preferred products and coverage parameters are consistent across the Medicaid Program. For more information, please visit: https://newyork.fhsc.com/providers/mat.asp

In addition, Fidelis Care has made changes to our Medicaid Managed Care, Child Health Plus (CHP), and HealthierLife (HARP) Formulary effective October 1, 2021. Some of the changes relate to quantity limitations, authorization requirements, as well as drugs being removed and added to the formulary. Please see the full list here.

 

Medicaid, Child Health Plus, and Healthier Life: Formulary Changes and Effective Dates

Part I: PA/ST/QL Removals & Formulary Additions

Drug

Action

Effective Date

Asenapine (Saphris)

Add with PA/QL

10/01/2021

Methylin Solution (brand)

≤ 18 y/o- Add with QL

>18 y/o- Add with PA/QL

10/01/2021

Silodosin (Rapaflo)

Add with ST/QL

10/01/2021

Clonidine ER (Kapvay)

Add with ST/QL

10/01/2021

Eligard

Add with PA

10/01/2021

Psyllium

Add

10/01/2021

Suboxone Film (BRAND)*

Add with QL

10/01/2021

Sublocade*

Add with QL

10/01/2021

* Change does NOT apply to Child Health Plus (CHP)

 

Part II: PA/ST/QL Additions & Formulary Removals

Drug

Action

Formulary Alternatives

Effective Date

Omnipod DASH

Add PA

 

09/01/2021

Nitro-Dur 0.3mg and 0.8mg Patch

Remove

· Nitroglycerin Patch (generic Nitro-Dur) 0.1 mg, 0.2 mg, 0.4 mg, 0.6mg

10/01/2021

Methylphenidate Solution (generic Methylin)

Remove

· Methylin solution (brand)

10/01/2021

Trientine (Syprine)

Remove

· Penicillamine tablet (generic Depen)- PA Req

10/01/2021

Lupron Depot 7.5mg, 22.5mg, 30mg, 45mg

Remove

· Eligard 7.5mg, 22.5mg, 30mg

10/01/2021

Buprenorphine/Naloxone Film (GENERIC Suboxone Film)*

Remove

· Suboxone Film (BRAND)

· Buprenorphine/Naloxone Tablet

10/01/2021

* Change does NOT apply to Child Health Plus (CHP)

 

PA- Prior Authorization | ST- Step Therapy | QL- Quantity Limit

Provider Access Online

Verify member eligibility/renewal, check claims status, and more.

Provider Bulletin

Read the latest Provider Bulletin and browse the archives.